CREON 1236 Pill - blue clear capsule/oblong, 25mm

Generic Name: pancrelipase

Pill with imprint CREON 1236 is Blue / Clear, Capsule/Oblong and has been identified as Creon 180,000 units amylase / 36,000 units lipase / 114,000 units protease. It is supplied by AbbVie, Inc.

Creon is used in the treatment of Pancreatic Exocrine Dysfunction; Chronic Pancreatitis; Cystic Fibrosis and belongs to the drug class digestive enzymes. Risk cannot be ruled out during pregnancy. Creon 180,000 units amylase / 36,000 units lipase / 114,000 units protease is not a controlled substance under the Controlled Substances Act (CSA).

Images for CREON 1236

Creon 180,000 units amylase / 36,000 units lipase / 114,000 units protease CREON 1236

Creon

Generic Name: pancrelipase
Imprint: CREON 1236
Strength: 180,000 units amylase / 36,000 units lipase / 114,000 units protease
Color: Blue / Clear
Size: 25.00 mm
Shape: Capsule/Oblong
Availability: Prescription only
Drug Class: Digestive enzymes
Pregnancy Category: C - Risk cannot be ruled out
CSA Schedule: Not a controlled drug
Labeler / Supplier: AbbVie, Inc.
National Drug Code (NDC): 00032-3016
Inactive Ingredients: hypromellose phthalate (31% phthalate, 40 cst), cetyl alcohol, dimethicone, triethyl citrate, titanium dioxide, FD&C Blue No. 2, sodium lauryl sulfate
Note: Inactive ingredients may vary.